Product Information
DEXAMETHASONE 2 MG TABLET is a generic product labeled by ANI Pharmaceuticals, Inc., priced at $0.2519 per EA under NDC 70954040210. Its NADAC has been published 165 times since Aug 9, 2023.
FDA first approved this application on May 9, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
2 mg/1
Manufacturer
ANI Pharmaceuticals, Inc.NDC
70954040210
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DEXAMETHASONEApproval Type
Generic (ANDA)
FDA Application
ANDA217696FDA Approved
5/9/2023
TE Code
AB
On Market Since
5/9/2023
Pharmacological Classes
Price Statistics
The NADAC for DEXAMETHASONE 2 MG TABLET has been published 165 times since Aug 9, 2023, and over the history we have for it it has declined 35.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2519 per EA |
|---|---|
| All-time high | $0.4420 (Jan 10, 2024) |
| All-time low | $0.2461 (Aug 19, 2026) |
| 52-week high | $0.3417 |
| 52-week low | $0.2461 |
| Median price | $0.3385 |
| Average price | $0.3334 |
| Largest weekly change | +34.4% (Aug 21, 2024) |
| Weeks tracked | 165 |
| Tracking since | Aug 9, 2023 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
ANI Pharmaceuticals, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Dexamethasone market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Corticosteroid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DEXAMETHASONE 2 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for DEXAMETHASONE 2 MG TABLET, manufactured by ANI Pharmaceuticals, Inc., is $0.2519 per EA (NDC 70954040210), effective Sep 30, 2026.
How has the price of DEXAMETHASONE 2 MG TABLET changed over time?
Over the history we have for it, the NADAC for DEXAMETHASONE 2 MG TABLET has declined 35.8%. It has been tracked across 165 weekly CMS publications since Aug 9, 2023.
What are the highest and lowest recorded NADAC prices for DEXAMETHASONE 2 MG TABLET?
Since Aug 9, 2023, the NADAC for DEXAMETHASONE 2 MG TABLET has ranged from a low of $0.2461 (Aug 19, 2026) to a high of $0.4420 (Jan 10, 2024), with a median of $0.3385 per EA.
Are there cheaper alternatives to DEXAMETHASONE 2 MG TABLET?
6 manufacturers publish a NADAC-priced product with the same active ingredient and strength as DEXAMETHASONE 2 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures DEXAMETHASONE 2 MG TABLET?
DEXAMETHASONE 2 MG TABLET (NDC 70954040210) is labeled by ANI Pharmaceuticals, Inc., and CMS classifies it as a generic product.